Defining polypharmacy in older adults: a cross-sectional comparison of prevalence estimates calculated according to active ingredient and unique product counts
Polypharmacy prevalence estimates varied substantially depending on the method applied. These data indicate the need for standardised reporting specific to medicines data and polypharmacy measures.
Authors
- Georgie Lee (ORCID: https://orcid.org/0000-0002-4343-3020)
- Christopher Etherton‐Beer (ORCID: https://orcid.org/0000-0001-5148-0188)
- Amy Page (ORCID: https://orcid.org/0000-0002-2084-8469)
- Sarah Hosking
- Kara L. Holloway‐Kew (ORCID: https://orcid.org/0000-0001-5064-2990)
- Lana J. Williams (ORCID: https://orcid.org/0000-0002-1377-1272)
- Julie Anne Pasco (ORCID: https://orcid.org/0000-0002-8968-4714)
Institutions
- Barwon Health (AU)
- Deakin University (AU)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Western Health (AU)
- Monash University (AU)
Publication Details
- Journal
- International Journal of Clinical Pharmacy
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1007/s11096-025-01882-7
- Citations
- 6
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 7.34
Funders
- Deakin University
- University of Western Australia
- Medical Research Council
- National Health and Medical Research Council